Walmart To Participate in KeyBanc Technology Leadership Forum
Get Alerts WMT Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.2%
EPS Growth %: +3.2%
Join SI Premium – FREE
BENTONVILLE, Ark.--(BUSINESS WIRE)-- Walmart Inc. (NYSE: WMT) announced today that Suresh Kumar, chief technology officer and chief development officer of Walmart Inc., will participate in a discussion at the KeyBanc Technology Leadership Forum on Thursday, Oct. 21, at 11:30 a.m. CDT.
The session will be webcast live through the “Events” link at www.stock.walmart.com.
A transcript of the session will be available after the event and will be archived on the company’s website.
About Walmart
Walmart Inc. (NYSE: WMT) helps people around the world save money and live better - anytime and anywhere – in retail stores, online, and through their mobile devices. Each week, approximately 220 million customers and members visit approximately 10,500 stores and clubs under 48 banners in 24 countries and eCommerce websites. With fiscal year 2021 revenue of $559 billion, Walmart employs over 2.2 million associates worldwide. Walmart continues to be a leader in sustainability, corporate philanthropy and employment opportunity. Additional information about Walmart can be found by visiting http://corporate.walmart.com, on Facebook at http://facebook.com/walmart and on Twitter at http://twitter.com/walmart.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211014005180/en/
Investor Relations Contacts
Dan Binder, CFA
Sr. Vice President, Investor Relations
479-295-2103
Michael Brigance
Sr. Director, Investor Relations
479-204-5646
Media Relations Contact
Randy Hargrove
Sr. Director, Global Communications
800-331-0085
Source: Walmart Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Solana Price Prediction 2030, 2040, 2050: Is $200 Next for SOL as Apeing Launch Fuels the Search for the Next Crypto to Watch?
- Zcash Price Prediction: ZEC Could Hit $1,800 After 89% Rally, But AlphaPepe Buyers Are Hunting Much Bigger Upside
- Pulmovant to Present Topline Results from the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) at the ERS Congress 2026 on
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
KeyBanc, Twitter, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share